Survey study, 2025
What causes premenstrual syndrome and premenstrual dysphoric disorder, and how common are they?
This review article explains the known biological, genetic and lifestyle factors behind premenstrual disorders rather than testing a treatment; it reports that any premenstrual disorder may affect up to 87% of women.
What they did
This is a narrative overview, not a trial. It summarises existing research on the types of premenstrual disorders and the biological mechanisms, genes and health conditions linked to them.
What they found
The prevalence of any premenstrual disorder is reported as up to 87% of women. Four variants of premenstrual disorders are described, including premenstrual exacerbation of other conditions. Fluctuations in hormones like estradiol, progesterone and testosterone, along with brain chemicals serotonin and GABA, are linked to symptoms. Several genes (SERT, COMT, MAOA, BDNF, ESR1, ESR2) have been studied in PMS. PMS is almost twice as common in women who are overweight or obese compared with normal-weight women, and women with metabolic syndrome and PMS tend to have poorer sleep and more depression and anxiety.
What it means for you
PMS and PMDD are common and involve a mix of hormones, genetics, and conditions like obesity and metabolic syndrome, so treatment may need to go beyond medication to include lifestyle changes and psychological support. As a review of existing studies, it does not provide new trial data and some findings, such as the obesity-related gene link, are described as controversial.
up to 87%
Prevalence of any premenstrual disorder
~2x higher
PMS rate in overweight/obese women
About the study
- Original title
- Current issues of the premenstrual disorders development
- Authors
- Iryna Oleksandrivna Kostitska, Nadiia Zherdova, А. Ya. Pavliak et al.
- Journal
- Reproductive health of woman
- Year
- 2025
- Study design
- Survey study
- What was tested
- None tested; this is a review of mechanisms and risk factors
- Open access
- Yes
- Read the paper
- doi.org/10.30841/2708-8731.2.2025.326506
Original abstract
Premenstrual disorders remain one of the most prevalent pathologies in women all over the world. The core disorders – premenstrual syndrome (PMS) and premenstrual dysphoric disorder – predominate in women of reproductive age. Also, there are four variants of premenstrual disorders – premenstrual exacerbation, premenstrual disorders due to nonovulatory ovarian activity, progestogen-induced premenstrual disorders, premenstrual disorders with absent menstruation. Recently, the prevalence of any premenstrual disorder is up to 87% in female population.In this article some mechanisms that are involved in the pathogenesis of PMS are presented. The fluctuations of different hormones (namely, estradiol, progesterone, testosterone, etc.) and not normal response of the central nervous system to such variations can lead to psychological changes. Serotonin, serotonin transporter, gamma amonibutyric acid are involved in the mechanisms of mood disorders. Genetic factor is studied in different woman’s reproductive diseases. Gene polymorphism of SERT, COMT, MAOA, BDNF, ESR1 and ESR2 genes were studied most often in PMS development. One of the subtypes of premenstrual disorders is premenstrual exacerbation, when clinical manifestations of underlying diseases are expressed more before menstruation. Special attention is paid to the association of metabolic syndrome, overweight, obesity with premenstrual syndrome. There is a negative impact of these diseases of the regulation of menstrual cycle processes – early menarche onset, abnormal uterine bleeding (irregular periods, heavy menstrual bleeding or amenorrhea), hyperandrogenism, low concentration of sex steroid-binding globulin. It was found that the frequency of PMS in overweight and obese women is almost twice higher than in normal weight women. Women with metabolic syndrome who suffer from PMS have poor sleep quality, they are more depressive and anxiety. The most common association of gene between obesity, diabetes mellitus and PMS is related to angiotensin converting enzyme gene and its I/D polymorphism, however, the results of such relationship are controversial. It is very important the for different medical professionals to understand the manifestations of premenstrual disorders and prescribe to the patients not only medicament treatment, but also perform for them psychological support and give recommendations about lifestyle changes.
Reproduced under CC-BY.
Topics
Related studies
Review, 2002
What are the reproductive-related mood disorders and how are they connected?
Survey study, 2026
Are PMDD, anxiety, and internet use linked to cognitive problems in women?
Study, 2025
Could taking a combination of vitamins and minerals help with PMS and PMDD symptoms?
Cohort study, 2023
Is PMDD a valid medical diagnosis?
Review, 2015
What do we know about PMS and PMDD and how are they treated?
Review, 2003
How do menstrual cycle hormones affect the brain and cause mood disorders like PMDD?